Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Gliff.ai, a UK-based producer of artificial intelligence software for healthcare and life science applications spun out of Durham University, has raised £375,000 ($500,000) in a round featuring Northern Accelerator, the regional academic alliance that also incorporates the universities of Newcastle, Sunderland and Northumbria, BusinessLive reported yesterday. Northern Accelerator’s Seed Investment Fund invested alongside early-stage venture firm Northstar Ventures, which participated both directly and through EU-backed North East Innovation Fund. Founded in 2018, Gliff.ai has focused on AI-driven medical diagnostics but now plans to branch out into more data science fields using cash from the round. Gliff.ai also aims to increase its 10-person headcount.
ILC Therapeutics, a UK-based covid-19 drug developer exploiting University of St Andrews research, has obtained an undisclosed sum from healthcare-focused incubator Medical Incubator Japan. The spinout has identified a synthetic interferon – proteins the body typically releases when virally infected – that it says kills covid-19…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?